<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">04531</article-id><article-id pub-id-type="doi">10.7554/eLife.04531</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genomics and Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>RNA virus attenuation by codon pair deoptimisation is an artefact of increases in CpG/UpA dinucleotide frequencies</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-18326"><name><surname>Tulloch</surname><given-names>Fiona</given-names></name><aff><institution content-type="dept">School of Biology</institution>, <institution>University of St Andrews</institution>, <addr-line><named-content content-type="city">St Andrews</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18325"><name><surname>Atkinson</surname><given-names>Nicky J</given-names></name><aff><institution content-type="dept">Infection and Immunity Division, Roslin Institute</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18328"><name><surname>Evans</surname><given-names>David J</given-names></name><aff><institution content-type="dept">School of Life Sciences</institution>, <institution>University of Warwick</institution>, <addr-line><named-content content-type="city">Coventry</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18327"><name><surname>Ryan</surname><given-names>Martin D</given-names></name><aff><institution content-type="dept">School of Biology</institution>, <institution>University of St Andrews</institution>, <addr-line><named-content content-type="city">St Andrews</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-18030"><name><surname>Simmonds</surname><given-names>Peter</given-names></name><aff><institution content-type="dept">Infection and Immunity Division, Roslin Institute</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country><email>Peter.Simmonds@ed.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-12145"><name><surname>Goff</surname><given-names>Stephen P</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Columbia University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>12</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e04531</elocation-id><supplementary-material><ext-link xlink:href="elife-04531-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>28</day><month>08</month><year>2014</year></date><date date-type="accepted"><day>08</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>Â© 2014, Tulloch et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Tulloch et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Mutating RNA virus genomes to alter codon pair (CP) frequencies and reduce translation efficiency has been advocated as a method to generate safe, attenuated virus vaccines. However, selection for disfavoured CPs leads to unintended increases in CpG and UpA dinucleotide frequencies that also attenuate replication. We designed and phenotypically characterised mutants of the picornavirus, echovirus 7, in which these parameters were independently varied to determine which most influenced virus replication. CpG and UpA dinucleotide frequencies primarily influenced virus replication ability while no fitness differences were observed between mutants with different CP usage where dinucleotide frequencies were kept constant. Contrastingly, translation efficiency was unaffected by either CP usage or dinucleotide frequencies. This mechanistic insight is critical for future rational design of live virus vaccines and their safety evaluation; attenuation is mediated through enhanced innate immune responses to viruses with elevated CpG/UpA dinucleotide frequencies rather the viruses themselves being intrinsically defective.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>A. thaliana</italic></kwd><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Virus</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>